Author:
Leighl Natasha B.,Dent Susan,Clemons Mark,Vandenberg Theodore A.,Tozer Richard,Warr David G.,Crump R. Michael,Hedley David,Pond Gregory R.,Dancey Janet E.,Moore Malcolm J.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide IARC cancer base No. 5. version 2.0. IARC Press, Lyon
2. Chia SKL, Speers C, Kang A et al (2003) The impact of new chemotherapeutic and hormonal agents on the survival of women with metastatic breast cancer (MBC) in a population based cohort. Proc Am Soc Clin Oncol 22:6 (abstr 22)
3. Stockler M, Wilcken N, Ghersi D, Simes RJ (2000) Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 26(3):151–168
4. Bergh J, Jonsson PE, Glimelius B et al (2001) A systematic overview of chemotherapy effects in breast cancer. Acta Oncol 40(2–3):253–281
5. Jones D, Ghersi D, Wilcken N (2006) Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database Syst Rev 3:CD003368
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献